Literature DB >> 19196865

A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation.

James Schuman1, Yuhong Chen, Andrew Podd, Mei Yu, Hong-Hsing Liu, Renren Wen, Zhijian J Chen, Demin Wang.   

Abstract

The kinase TAK1 is essential for T-cell receptor (TCR)-mediated nuclear factor kappaB (NF-kappaB) activation and T-cell development. However, the role of TAK1 in B-cell receptor (BCR)-mediated NF-kappaB activation and B-cell development is not clear. Here we show that B-cell-specific deletion of TAK1 impaired the transition from transitional type 2 to mature follicular (FO) B cells and caused a marked decrease of marginal zone (MZ) B cells. TAK1-deficient B cells exhibited an increase of BCR-induced apoptosis and impaired proliferation in response to BCR ligation. Importantly, TAK1-deficient B cells failed to activate NF-kappaB after BCR stimulation. Thus, TAK1 is critical for B-cell maturation and BCR-induced NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196865      PMCID: PMC2680363          DOI: 10.1182/blood-2008-08-176057

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

1.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.

Authors:  T Akagi; T Shishido; K Murata; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 3.  B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory".

Authors:  F Martin; J F Kearney
Journal:  Immunol Rev       Date:  2000-06       Impact factor: 12.988

Review 4.  B-1 cells: the lineage question revisited.

Authors:  L A Herzenberg
Journal:  Immunol Rev       Date:  2000-06       Impact factor: 12.988

5.  The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.

Authors:  M Grossmann; L A O'Reilly; R Gugasyan; A Strasser; J M Adams; S Gerondakis
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

6.  Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure.

Authors:  J Ruland; G S Duncan; A Elia; I del Barco Barrantes; L Nguyen; S Plyte; D G Millar; D Bouchard; A Wakeham; P S Ohashi; T W Mak
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

7.  The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

Authors:  C Chen; L C Edelstein; C Gélinas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

8.  Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases.

Authors:  Jesus M Salvador; Paul R Mittelstadt; Tad Guszczynski; Terry D Copeland; Hiroshi Yamaguchi; Ettore Appella; Albert J Fornace; Jonathan D Ashwell
Journal:  Nat Immunol       Date:  2005-02-27       Impact factor: 25.606

Review 9.  An unsolved problem of the clonal selection theory and the model of an oligomeric B-cell antigen receptor.

Authors:  M Reth; J Wienands; W W Schamel
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

10.  Nuclear factor kappa B is required for the development of marginal zone B lymphocytes.

Authors:  A Cariappa; H C Liou; B H Horwitz; S Pillai
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

View more
  39 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

2.  Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function.

Authors:  Yanyan Wang; Gonghua Huang; Peter Vogel; Geoffrey Neale; Boris Reizis; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

3.  Essential role of TAK1 in regulating mantle cell lymphoma survival.

Authors:  Daniela Buglio; Sangeetha Palakurthi; Kate Byth; Francisco Vega; Dorin Toader; Jamal Saeh; Sattva S Neelapu; Anas Younes
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

4.  In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).

Authors:  Harminder S Dua; Ahmad Muneer Otri; Andrew Hopkinson; Imran Mohammed
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

5.  Structure-guided development of covalent TAK1 inhibitors.

Authors:  Li Tan; Deepak Gurbani; Ellen L Weisberg; John C Hunter; Lianbo Li; Douglas S Jones; Scott B Ficarro; Samar Mowafy; Chun-Pong Tam; Suman Rao; Guangyan Du; James D Griffin; Peter K Sorger; Jarrod A Marto; Kenneth D Westover; Nathanael S Gray
Journal:  Bioorg Med Chem       Date:  2016-12-09       Impact factor: 3.641

Review 6.  TAK1 regulates hepatic cell survival and carcinogenesis.

Authors:  Yoon Seok Roh; Jingyi Song; Ekihiro Seki
Journal:  J Gastroenterol       Date:  2014-01-21       Impact factor: 7.527

7.  TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.

Authors:  Michitaka Oho; Risa Nakano; Ryutarou Nakayama; Wataru Sakurai; Azusa Miyamoto; Yoshikazu Masuhiro; Shigemasa Hanazawa
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

8.  TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.

Authors:  Betty Lamothe; YunJu Lai; Min Xie; Michael D Schneider; Bryant G Darnay
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

9.  An essential role for TAK1 in the contact hypersensitivity response.

Authors:  Yan G Zhao; Yunqi Wang; Weidong Hao; Yisong Y Wan
Journal:  Cell Mol Immunol       Date:  2011-05-09       Impact factor: 11.530

10.  CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.

Authors:  Mélanie Juilland; Montserrat Gonzalez; Tabea Erdmann; Yara Banz; Zala Jevnikar; Stephan Hailfinger; Alexandar Tzankov; Michael Grau; Georg Lenz; Urban Novak; Margot Thome
Journal:  Blood       Date:  2016-01-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.